Java Development Kit (JDK) 26, a planned update to standard Java due March 17, 2026, has reached its second release candidate (RC) stage. The RC is open for critical bug fixes, with the feature set ...

Dublin, Feb. 11, 2026 (GLOBE NEWSWIRE) -- The "International Directory of Generics Companies" directory has been added to ResearchAndMarkets.com's offering. This powerful directory is your connection ...

The following is a news release from the Idaho Attorney General's Office: BOISE, Idaho — On February 2, 2026, Attorney General Labrador joined a coalition of 48 states and territories announcing ...

— Adrian García, CEO of Saya Bio. MEXICO CITY, MEXICO, January 26, 2026 /EINPresswire.com/ — Saya Biologics (Saya Bio), a Mexican biopharmaceutical company ...

CORRECTION: An earlier version of this story said Health Canada had approved several generics for semaglutide. They have received several submissions for approval for ...

As the midterm election year gets underway, voters are already drawing clear lines between the Democratic and Republican parties on the issues. A new Fox News survey, released Thursday, finds the ...

This weight-loss leader was drubbed last year. It's a popular pick as a 2026 rebound candidate. More than that popularity, it has credible catalysts to bounce back this year. Fast-forward to 2026, and ...

Democrats are ahead of Republicans by 6 percentage points on a generic congressional ballot, according to a poll released Thursday. In the Emerson College poll, 48.1 percent of respondents backed a ...

The Democratic Party has a deeply motivated base and a clear advantage on the generic congressional ballot ahead of this fall’s midterms despite dismal impressions of its current leaders in Congress, ...

British Columbians could soon have access to cheaper versions of injectable diabetes and obesity drugs. Health Canada is reviewing nine submissions for generic versions of semaglutide, a prescription ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...